Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial)

Sex-Specific Differences In Late Mortality After Transcatheter AVR In The PARTNER Trial

Stenting During STEMI Is Associated With Less Neointimal Hyperplasia: A Pooled IVUS Analysis From The HORIZONS-AMI And Taxus IV, V, And ATLAS Trials

TCT-112 Left Ventricular Ejection Fraction Improves Less after Trans-Apical Transcatheter Aortic Valve Replacement Compared to a Trans-Femoral Approach

TCT-113 Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

TCT-114 Impact of Left Ventricular Function on Outcomes of Transcatheter Aortic Valve Replacement and Medical Therapy in Inoperable Patients with Aortic Stenosis: Insights from the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B)

TCT-19 The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

TCT-236 Clinical Profile And Impact Of A Family History Of Premature Coronary Artery Disease On Long-term Clinical Ischemic Events In Patients Undergoing PCI For STEMI: Analysis From The HORIZONS-AMI Trial. Revascularization And Stents In Acute Myocardial Infarction) Trial.

TCT-261 Safety and efficacy of Bivalirudin monotherapy in patients with non-ST segment elevation myocardial infarction undergoing PCI: Results from the ACUITY Study

TCT-292 reduced bleeding complications and increased event-free survival with femoral vascular closure device use and bivalirudin in stemi patients undergoing primary angioplasty in the horizons-ami trial